Amphastar Pharmaceuticals, Inc. (AMPH) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 6 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for AMPH is $30.00, representing a +40.3% upside from the current price of $21.38. Price targets range from a low of $30.00 to a high of $30.00.
